Doctor profile · Federal record

Dr. Laura Nadeau, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Royal Oak, MI

  • NPI 1457340390
  • Accepts Medicare
  • 32 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3577 W 13 Mile RD, Suite 103
Royal Oak, MI 480736710
(248) 288-4500
fax (248) 288-0450

Credentials & registration

NPPES · NUCC
NPI registered
October 2005 — 21 yrs on file
Profile last updated
October 19, 2020
Year of graduation
1994 — 32 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Michigan #4301085691

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1457340390. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
76,247
Distinct HCPCS
10
Medicare allowed
$845,139
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 26,520 37 $0
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram 23,700 24 $0
J0897 Injection, denosumab, 1 mg 8,220 51 $23
J9271 Injection, pembrolizumab, 1 mg 6,000 16 $54
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 1,460 20 $7
36415 Insertion of needle into vein for collection of blood sample 1,270 523 $8
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,231 511 $8
J2469 Injection, palonosetron hcl, 25 mcg 720 38 $1
J1100 Injection, dexamethasone sodium phosphate, 1 mg 686 42 $0
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 590 14 $7

In context: peer comparison

Among 8 peers in Royal Oak Hematology & Oncology Physician, average services per provider: 1,850. This provider delivers 41× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,237
Transactions
91
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 23 $353.28
Genentech USA, INC. 14 $256.34
Janssen Biotech, INC. 8 $247.11
Daiichi Sankyo INC. 8 $161.36
Gilead Sciences, INC. 7 $130.07
Merck Sharp & Dohme LLC 6 $124.65
Eisai INC. 4 $83.38
TerSera Therapeutics LLC 3 $74.50
Genzyme Corporation 3 $67.96
Abbvie INC. 3 $63.25
Lilly USA, LLC 3 $61.99
Pfizer INC. 3 $60.38
E.R. Squibb & Sons, L.L.C. 3 $52.01
Regeneron Healthcare Solutions, INC. 1 $41.53
Emd Serono, INC. 2 $36.39

By nature of payment

Food and Beverage
$2,149
Education
$88

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,142
Patients
329
Total drug cost
$1,464,283
Drug Type Claims Patients Total cost
Anastrozole Generic 296 81 $17,401
Letrozole Generic 188 56 $12,589
Eliquis (Apixaban) Brand 98 27 $105,779
Tamoxifen Citrate Generic 65 23 $2,662
Exemestane Generic 64 22 $16,728
Alprazolam Generic 52 15 $283
Ibrance (Palbociclib) Brand 50 0 $778,888
Lorazepam Generic 47 16 $750
Prochlorperazine Maleate Generic 46 36 $1,741
Omeprazole Generic 43 15 $472

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Laura Nadeau's medical specialty?
Dr. Laura Nadeau practices Hematology & Oncology Physician in Royal Oak, MI.
Where does Dr. Laura Nadeau practice?
Dr. Laura Nadeau practices at 3577 W 13 Mile RD, Royal Oak, MI 480736710. Office phone: 2482884500.
What is Dr. Laura Nadeau's NPI?
Dr. Laura Nadeau's National Provider Identifier (NPI) is 1457340390, issued by NPPES.
Does Dr. Laura Nadeau accept Medicare assignment?
Yes. Dr. Laura Nadeau accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Laura Nadeau commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.